Selank: Dosage & Administration
Part of the Selank Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Selank Dosage Protocols
Selank is administered intranasally or subcutaneously. The approved Russian formulation provides specific clinical dosing guidelines, while research protocols vary:
| Route | Dose | Frequency | Application |
|---|---|---|---|
| Intranasal (0.15%) | 250–500 mcg per nostril | 2–3× daily | Anxiolytic, cognitive |
| Subcutaneous | 250–750 mcg | Once daily | Research protocols |
In the approved Russian formulation, the standard regimen is 2-3 drops per nostril, 3 times daily, for a course of 14 days. Subcutaneous protocols typically follow similar total daily doses.
Administration Details
Intranasal
Intranasal delivery provides rapid absorption through the nasal mucosa and potentially enhanced brain delivery via the olfactory pathway. Clear nasal passages before administration. Tilt head slightly forward, insert dropper, and inhale gently.
Subcutaneous
Standard subcutaneous injection technique applies. Reconstitute lyophilized powder with bacteriostatic water. Use the peptide calculator for reconstitution volumes. See the injection guide for technique.
Cycle Length & Timing
The approved Russian protocol recommends 10–14 day treatment courses with rest periods between courses. Research protocols have studied continuous use for up to 30 days.
- Standard course: 10–14 days
- Extended course: Up to 30 days in some research protocols
- Rest period: 1–2 weeks between courses (per Russian clinical guidelines)
- Timing: Morning and afternoon dosing preferred; avoid evening administration if stimulating effects are noticed
Unlike benzodiazepines, Selank does not develop tolerance with repeated use, and no withdrawal symptoms have been reported after discontinuation.